Bussiness5 months ago
Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Axsome Therapeutics, Inc. Total 2Q 2024 net product revenue of $87.2 million, representing 87% year-over-year growth Auvelity® 2Q 2024 net product sales of $65.0 million, representing...
